谷歌浏览器插件
订阅小程序
在清言上使用

Safety and Efficacy of Bezuclastinib ( CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (advsm): Results from Part 1 of the Phase 2 Apex Trial

BLOOD(2023)

引用 0|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要